Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels

[1]  M. Portero-Otín,et al.  Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species , 2015, Journal of neuropathology and experimental neurology.

[2]  D. Munoz,et al.  Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation , 2015, EMBO molecular medicine.

[3]  R. Vemuganti,et al.  Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries , 2014, Molecular Neurobiology.

[4]  Richard D. Smith,et al.  Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. , 2014, Cell metabolism.

[5]  M. Garcia-Alloza,et al.  Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice , 2014, Psychoneuroendocrinology.

[6]  F. J. Romero,et al.  Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy , 2014, Oxidative medicine and cellular longevity.

[7]  Palaniyandi Ravanan,et al.  A Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and Oxidative Stress , 2014, Front. Cell. Neurosci..

[8]  C. Hölscher.  First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease , 2014, Alzheimer's & Dementia.

[9]  M. Riemenschneider,et al.  Unfolded protein response signaling by transcription factor XBP‐1 regulates ADAM10 and is affected in Alzheimer's disease , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Ming Lu,et al.  Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice , 2014, Experimental Neurology.

[11]  D. Berman,et al.  Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease , 2014, Neurobiology of Disease.

[12]  Y. Shimomura,et al.  Regulation of hepatic branched-chain α-ketoacid dehydrogenase complex in rats fed a high-fat diet. , 2013, Obesity research & clinical practice.

[13]  J. Quevedo,et al.  Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model , 2013, Journal of Inherited Metabolic Disease.

[14]  V. Carraro,et al.  The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression , 2013, Nucleic acids research.

[15]  C. Hölscher,et al.  Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence , 2013, CNS Drugs.

[16]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[17]  M. Bogo,et al.  Acute and Chronic Administration of the Branched-Chain Amino Acids Decreases Nerve Growth Factor in Rat Hippocampus , 2013, Molecular Neurobiology.

[18]  M. Garcia-Alloza,et al.  Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. , 2012, American journal of physiology. Endocrinology and metabolism.

[19]  M. Laakso,et al.  Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice , 2012, Journal of cellular and molecular medicine.

[20]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[21]  B. Platt,et al.  Susceptibility to diet-induced obesity and glucose intolerance in the APPSWE/PSEN1A246E mouse model of Alzheimer’s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein , 2011, Diabetologia.

[22]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[23]  R. Zechner,et al.  Brain insulin controls adipose tissue lipolysis and lipogenesis. , 2011, Cell metabolism.

[24]  D. Cai,et al.  Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress , 2011, Proceedings of the National Academy of Sciences.

[25]  Rudolph E Tanzi,et al.  Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid-β Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex , 2010, The Journal of Neuroscience.

[26]  A. Matteucci,et al.  Branched-Chain Amino Acids Induce Neurotoxicity in Rat Cortical Cultures , 2010, Neurotoxicity Research.

[27]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[28]  Jason Chung,et al.  Endoplasmic reticulum stress plays a central role in development of leptin resistance. , 2009, Cell metabolism.

[29]  J. Backer,et al.  Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. , 2008, The Journal of clinical investigation.

[30]  Nicholas E. Bruns,et al.  A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy , 2008, Proceedings of the National Academy of Sciences.

[31]  Simon Lovestone,et al.  The GSK3 hypothesis of Alzheimer's disease , 2008, Journal of neurochemistry.

[32]  M. Jäättelä,et al.  Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium , 2007, Cell Death and Differentiation.

[33]  M. Haan.  Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease , 2006, Nature Clinical Practice Neurology.

[34]  M. Folstein,et al.  Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis , 2006, Neurobiology of Aging.

[35]  D. Porte,et al.  Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. , 2005, Diabetes.

[36]  M. Ristow,et al.  Neurodegenerative disorders associated with diabetes mellitus , 2004, Journal of Molecular Medicine.

[37]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[38]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[40]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[41]  James P. O'Callaghan,et al.  Time Course of the Development of Alzheimer-like Pathology in the Doubly Transgenic PS1+APP Mouse , 2002, Experimental Neurology.

[42]  S. Mudaliar,et al.  Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. , 2000, Diabetes.

[43]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[44]  A. Ott.  Risk of dementia: The Rotterdam Study , 1997 .

[45]  C. Wolfgang,et al.  Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10 , 1996, Molecular and cellular biology.

[46]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[47]  F. Gage,et al.  Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor , 1987, Nature.

[48]  T. Tabira,et al.  Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease. , 2013, Current Alzheimer research.

[49]  N. Cheung,et al.  Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. , 2012, Journal of Alzheimer's disease : JAD.

[50]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.

[51]  D. Selkoe,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.